Baxter International | BAX - Current Liabilities

Stock Price
18.16
Daily Change
-0.25 -1.36%
Monthly
6.07%
Yearly
-39.91%
Q2 Forecast
18.30

Baxter International reported $2.97B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 101.56M 15.72M Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Avanos Medical USD 165.2M 17.3M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
ICU Medical USD 498.86M 5.96M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Laboratory Of America USD 2.82B 194.3M Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Terumo JPY 539.7B 243.4B Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025